{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:56:15Z","timestamp":1772042175191,"version":"3.50.1"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.18632\/oncotarget.24877","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T10:21:41Z","timestamp":1522664501000},"page":"17725-17734","source":"Crossref","is-referenced-by-count":11,"title":["The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke"],"prefix":"10.18632","volume":"9","author":[{"given":"Xingyang","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Deyang City, Deyang 618000, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Deyang City, Deyang 618000, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Deyang City, Deyang 618000, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Deyang City, Deyang 618000, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1747-4949.2007.00142.x","article-title":"Burden of stroke in china","volume":"2","author":"Wang","year":"2007","journal-title":"Int J Stroke"},{"key":"2","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/STROKEAHA.107.502807","article-title":"Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project","volume":"39","author":"Wu","year":"2008","journal-title":"Stroke"},{"key":"3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kittner","year":"2014","journal-title":"Stroke"},{"key":"5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-142-5-200503010-00012","article-title":"Narrative review: aspirin resistance and its clinical implications","volume":"142","author":"Kinmonth","year":"2005","journal-title":"Ann Intern Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"O\u2019Connor","year":"2003","journal-title":"Circulation"},{"key":"7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00415-016-8181-5","article-title":"Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population","volume":"263","author":"Chen","year":"2016","journal-title":"J Neurol"},{"key":"8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1747-4949.2012.00929.x","article-title":"Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events","volume":"8","author":"Chi","year":"2013","journal-title":"Int J Stroke"},{"key":"9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00228-017-2198-2","article-title":"Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke","volume":"73","author":"Fu","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Rodriguez-Antona","year":"2007","journal-title":"Pharmacol Ther"},{"key":"13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5551\/jat.33290","article-title":"Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke","volume":"23","author":"Chi","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.089599","article-title":"Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension","volume":"50","author":"Schwartzman","year":"2007","journal-title":"Hypertension"},{"key":"15","doi-asserted-by":"publisher","first-page":"70811","DOI":"10.18632\/oncotarget.19991","article-title":"Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Xu","year":"2013","journal-title":"N Engl J Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1076029614551823","article-title":"Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke","volume":"21","author":"Chi","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"18","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","article-title":"A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke","volume":"23","author":"Chi","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"19","first-page":"183","article-title":"The human cytochrome P450 allele nomenclature committee web site: submission criteria, procedures, and objectives","volume":"320","author":"Ingelman-Sundberg","year":"2006","journal-title":"Methods Mol Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/01.STR.30.8.1716","article-title":"Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel","volume":"30","author":"Pepine","year":"1999","journal-title":"Stroke"},{"key":"21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Sabatine","year":"2009","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Becquemont","year":"2009","journal-title":"N Engl J Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Parsa","year":"2009","journal-title":"JAMA"},{"key":"24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/STROKEAHA.113.000823","article-title":"CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China","volume":"44","author":"Xu","year":"2013","journal-title":"Stroke"},{"key":"25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol Ther"},{"key":"26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1756285616681943","article-title":"Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke","volume":"10","author":"Wang","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"key":"27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00207454.2012.744308","article-title":"Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention","volume":"123","author":"Stanslas","year":"2013","journal-title":"Int J Neurosci"},{"key":"28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/09537104.2014.953044","article-title":"Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel","volume":"26","author":"Guo","year":"2015","journal-title":"Platelets"},{"key":"29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3949\/ccjm.78a.10145","article-title":"Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others","volume":"78","author":"Sadee","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"31","first-page":"2221","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Longtine","year":"2011","journal-title":"JAMA"},{"key":"32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Rupprecht","year":"2004","journal-title":"Lancet"},{"key":"33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Bassand","year":"2010","journal-title":"Lancet"},{"key":"34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.026","article-title":"Antiplatelet agents for the secondary prevention of ischemic stroke or transient ischemic attack: a network meta-analysis","volume":"25","author":"Zhao","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"35","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/euhj.1998.1042","article-title":"Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis","volume":"19","author":"Litvack","year":"1998","journal-title":"Eur Heart J"},{"key":"36","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/01.STR.0000169922.79281.a5","article-title":"Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease","volume":"36","author":"Mannhalter","year":"2005","journal-title":"Stroke"},{"key":"37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000098059","article-title":"A new subtype classification of ischemic stroke based on treatment and etiologic mechanism","volume":"57","author":"Heo","year":"2007","journal-title":"Eur Neurol"},{"key":"38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"The GUSTO Investigators","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:37:43Z","timestamp":1589038663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":38,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["24877","29707143"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24877","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]}}}